Ernexa Therapeutics, Inc. (ERNA)
1.36
-0.27
(-16.56%)
USD |
NASDAQ |
Nov 20, 16:00
1.41
+0.05
(+3.68%)
After-Hours: 20:00
Ernexa Therapeutics Total Assets (Quarterly) : 7.104M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.104M |
| June 30, 2026 | 6.315M |
| March 31, 2026 | 10.54M |
| December 31, 2025 | 5.834M |
| September 30, 2025 | 6.172M |
| June 30, 2025 | 7.584M |
| March 31, 2025 | 5.059M |
| December 31, 2024 | 5.269M |
| September 30, 2024 | 7.718M |
| June 30, 2024 | 46.49M |
| March 31, 2024 | 49.66M |
| December 31, 2023 | 49.13M |
| September 30, 2023 | 52.25M |
| June 30, 2023 | 46.95M |
| March 31, 2023 | 15.11M |
| December 31, 2022 | 22.28M |
| September 30, 2022 | 20.93M |
| June 30, 2022 | 26.90M |
| March 31, 2022 | 35.38M |
| December 31, 2021 | 31.52M |
| September 30, 2021 | 39.39M |
| June 30, 2021 | 64.71M |
| March 31, 2021 | 20.70M |
| December 31, 2020 | 13.78M |
| September 30, 2020 | 5.054M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.79M |
| March 31, 2020 | 11.01M |
| December 31, 2019 | 15.28M |
| September 30, 2019 | 14.92M |
| June 30, 2019 | 15.64M |
| March 31, 2019 | 16.48M |
| December 31, 2018 | 14.86M |
| September 30, 2018 | 15.54M |
| June 30, 2018 | 16.36M |
| March 31, 2018 | 15.70M |
| December 31, 2017 | 16.57M |
| September 30, 2017 | 17.56M |
| June 30, 2017 | 18.53M |
| March 31, 2017 | 17.53M |
| December 31, 2016 | 17.14M |
| September 30, 2016 | 14.40M |
| June 30, 2016 | 14.96M |
| March 31, 2016 | 16.32M |
| December 31, 2015 | 16.82M |
| September 30, 2015 | 17.28M |
| June 30, 2015 | 17.24M |
| March 31, 2015 | 20.16M |
| December 31, 2014 | 22.95M |
| September 30, 2014 | 22.56M |
| June 30, 2014 | 22.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cerenome, Inc. | 12.20M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.753M |
| Shareholders Equity (Quarterly) | 4.351M |
| Debt to Equity Ratio | 0.071 |
| Current Ratio | 2.574 |
| Net Debt Paydown Yield | 1.08% |